Molecular subtypes based on DNA promoter methylation predict prognosis in lung adenocarcinoma patients

Background: The heterogeneity of lung adenocarcinoma (LADC) makes the early diagnosis and treatment of the disease difficult. Gene silencing of DNA methylation is an important mechanism of tumorigenesis. A combination of methylation and clinical features can improve the classification of LADC hetero...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Shanping, Xu, Mingjun, Xi, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762488/
https://www.ncbi.nlm.nih.gov/pubmed/33237038
http://dx.doi.org/10.18632/aging.104062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762488/
https://www.ncbi.nlm.nih.gov/pubmed/33237038
http://dx.doi.org/10.18632/aging.104062

Ejemplares similares